Danielle Benoit Ph.D. is a professor in the Biomedical Engineering department at the University of Rochester. She is also director of the Material Science and Engineering Department. Her research focuses on the development of therapeutic biomaterials with tunable degradation and mechanical properties for regenerative medicine needs. She has expertise in polymer synthesis and nanoparitcle design for drug delivery and tissue engineering applications. She works on the development of salivary gland tissue chips using Nidus MBATM for radio protective drug discovery. She brings expertise in the development of Nidus technology for applications in tissue chip and organoid culture for HTS screening.
Benjamin Miller, Ph.D. Is a Professor at the University of Rochester in the Department of Dermatology with secondary appointments in Biomedical Engineering, Biochemistry and Biophysics. His Lab studies biomolecular interactions through the synthesis of molecular probes and through the development of novel optical sensing technologies. He pioneered the development of arrayed imaging reflectometry (AIR) that has been commercialized through Adarza BioSystems for multiplex detection of pathogens and immune markers.
Johnathan Rebhahn, M.S. Is a Technical Associate in the Human Immunology Center at the University of Rochester. He is an imaging software development expert trained in data science/computational biology. He has contributed extensively to the development of IMAATTM software.
Michael R. King Ph.D. is the J. Lawrence Wilson Professor of Engineering at Vanderbilty UNiversity. He is also the Chair of the Biomedical Engineering and a Professor of Radiology and Radiological Sciences. He is a fellow of the American Institute for Medical and Biological Engineering and of the Biomedical Engineering Society. The King Lab studies receptor-mediated adhesion of circulating cells, and has developed computational and in vitro models to study the function of leukocytes, platelets, stem and circulating tumor cells under flow. Dr. King brings expertise in application of Nidus technology to cancer research.
James McGrath Ph.D. is a professor in the Biomedical Engineering Department at the University of Rochester. He leads the Nanomembrane Research Group that develops applications using ultrathin (15 nm – 400 nm) porous materials fabricated using silicon-base manufacturing. He is a co-founder of SiMPore Inc. that has commercialized this technology. Dr. McGrath brings expertise in microfluidics, silicon-based engineering and know how in developing novel devices.
